I joined the CTIM lab in 2019 after obtaining Joint-CSIR-UGC-JRF,and upgraded to SRF in 2022. I have done my graduation and postgraduation in general biotechnology from St. Mary’s college Thrissur. My work at CTIM is to investigate the immunological role of pro- angiogenic chemokines in triple negative breast cancer microenvironment and to find potentialdrug targets to improve immunotherapy.

Email : hima.xavier@mic.ac.in

I joined the CTIM lab in 2020 after obtaining Joint-CSIR-UGC-JRF and upgraded to SRF in 2023. I have done my graduation and postgraduation in zoology under Kerala University. My research work at CTIM focuses on targeting chemoattractant cytokines in tumor thereby improve vasculature and enhance immune surveillance in triple negative breast cancer.

Email : athira.gireesh@mic.ac.in

I joined the CTIM in 2022 after obtaining Joint-CSIR-UGC-JRF. I had my graduation from Mar Thoma College Thiruvalla and post-graduated from Mar Ivanios College, Tvm. My work here at CTIM focusses on the efficacy of Nano-Immuno therapy based blockade of CXCL-3 —CXCR-2 pathway to improve immune surveillance in obese murine breast cancer model.

Email : juvin.thomas@mic.ac.in

I joined the CTIM in 2023 after obtaining INSPIRE-JRF. I had my graduation from Mar Ivanios College, Thiruvananthapuram, and post-graduated from the University of Kerala, Kariavattom Campus, Thiruvananthapuram. My work here at CTIM focuses on the “Nano-Immunotherapy based blockade of iNOS pathway to improve immune surveillance in obese murine breast cancer model”.

Email : emmanuel.biju@mic.ac.in

I joined the CTIM in 2023 after obtaining JOINT-CSIR-UGC-JRF. I had my graduation from NSS College, Cherthala, Alappuzha, and post-graduated from SD College, Alappuzha. My work here at CTIM focuses on the “Blockade of CCL17-CCR4 axis to improve immune surveillance in murine triple negative breast cancer model”.

Email : aryameera97@gmail.com

I joined the CTIM in 2023 after obtaining JOINT-CSIR-UGC- JRF. I had my graduation from MG College, Thiruvananthapuram, and post-graduated from SN college, Cherthala, Alappuzha. My work here at CTIM focuses on the “N-(2,3-Dichloro-phenyl)-2-(2-methyl-quinolin-4-ylamino)- acetamide-(PS-9) mediated blockade of CXCL3 - CXCR2 axis to normalizes tumor vasculature and enhances immune surveillance in triple negative breast cancer”.

Email : aryaraj339@gmail.com